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Traumatic brain injury (TBI) is the leading cause of death and disability in individuals
below age 45, and five million Americans live with chronic disability as a result. Mild
TBI (mTBI), defined as TBI in the absence of major imaging or histopathological
defects, is responsible for a majority of cases. Despite the lack of overt morphological
defects, victims of mTBI frequently suffer lasting cognitive deficits, memory difficulties,
and behavioral disturbances. There is increasing evidence that cognitive and memory
dysfunction is related to subtle physiological changes that occur in the hippocampus,
and these impact both the phenotype of deficits observed and subsequent recovery.
Therapeutic modulation of physiological activity by means of medications commonly
used for other indications or brain stimulation may represent novel treatment
approaches. This review summarizes the present body of knowledge regarding
neurophysiologic changes that occur in the hippocampus after mTBI, as well as potential
targets for therapeutic modulation of neurologic activity.
Keywords: hippocampus, mild traumatic brain injury, neurophysiology, neuromodulation, cognitive dysfunction,
drug repositioning
INTRODUCTION
Every year, one out of every 200 people worldwide will suffer a traumatic brain injury (TBI),
including 1.7 million people in the United States alone, with an annual associated cost of
approximately $76.5 billion (Faul et al., 2010). It is estimated that 5.3 million Americans live with
long-term disability as a result of their injury (Centers for Disease Control and Prevention [CDC],
2013). Young men and the elderly are particularly vulnerable because of an increased incidence
of trauma and falls, respectively (Susman et al., 2002). TBI is also prevalent in the military, with
approximately 20% of all returning deployed American troops suffering some form of brain injury
from a blast exposure (Terrio et al., 2009), the vast majority of these being mild injuries.
Mild TBI (mTBI), sometimes termed concussion, accounts for 75% of all head injuries
(Faul et al., 2010). Symptoms include headache, sleep impairment, memory deficit, difficulty
concentrating (Levin et al., 1987), and an increased incidence of affective disorders such as
depression and anxiety (Park et al., 2008). These clinical problems are persistent and severe
in 10% of cases, lasting for months to years, sometimes indefinitely (Greig et al., 2014).
Due to the striking prevalence and disruptive clinical manifestations of mTBI, research has
focused on elucidating the pathophysiological mechanisms underlying primary and secondary
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brain injury in order to develop therapies that may alter
or prevent these processes. More recently, changes in neural
circuitry underlying many of the clinical manifestations of mTBI,
especially memory and affective disorders, has been studied
in an attempt to understand mechanisms of disruption and
how modulation of these networks may be used to therapeutic
advantage. In order to determine how novel neuromodulation
treatments might be able to improve TBI-associated deficits,
it is important to establish how individual neurons and
subpopulations of neurons contribute to network activity and
how these networks respond to injury. This review will discuss
neurophysiological changes in the hippocampus associated with
mTBI, and ways in which therapeutic neuromodulation might be
used to reverse these deficits.
BIOCHEMICAL AND GENETIC CHANGES
IN THE HIPPOCAMPUS FOLLOWING TBI
Neurological injury that occurs after a traumatic insult
can result from two different mechanisms: primary and
secondary injury. Primary injury refers to the mechanical
forces of shearing and compression at the time of impact,
while secondary injury involves the subsequent cascade of
pathological events that occurs minutes to days after the
insult (Greve and Zink, 2009). Such secondary processes
include hypoxia/ischemia, edema, raised intracranial pressure,
excitotoxity through glutamate release, calcium dysregulation,
cytoskeletal proteolysis, free radical oxidative damage, altered
synaptic physiology, cytokine release causing inflammation, and
ultimately neuronal cell death (Choi et al., 1987; Raghupathi,
2004; Maas et al., 2008; Barkhoudarian et al., 2011; Greig et al.,
2014; Merlo et al., 2014). These secondary injury mechanisms
are especially important for therapeutic consideration as they can
theoretically be altered or inhibited with the aim of preventing
injury or protecting brain tissue that has the potential to
recover.
There are several commonalities between the biochemical
cascades involved in secondary mTBI injury mechanisms and
those found in degenerative central nervous system (CNS)
diseases such as Parkinson’s disease (PD; Eakin and Miller,
2012; van Bregt et al., 2012), Alzheimer’s disease (AD),
Huntington’s disease (HD), and amyotrophic lateral sclerosis
(Daneshvar et al., 2011). As a result, pathways that have been
extensively characterized in these diseases can be extrapolated
and applied to analogous pathways involved in TBI in order
to better understand the mechanisms of injury and potential
novel therapeutic approaches. This has important implications
for diagnosis: a complex mathematical model of semantic
predications was recently used to search almost 100,000 citations
of neural injury networks and produced a list of 17 potential
biomarkers that may indicate mTBI, with glutamate, glucose,
and lactate being the most common (Cairelli et al., 2015). In
combination with other compounds, such as the apolipoprotein
E-4 allele which adversely influences recovery following brain
injury (Lawrence et al., 2015), these biomarkers may aid in the
early diagnosis of mTBI, allowing the prompt administration of
neuroprotective drugs or neuromodulatory therapies.
Glutamate is particularly important, as this excitatory
neurotransmitter is known to play a strong role in secondary
injury mechanisms throughout the brain. Microdialysis studies,
in both rodents (Folkersma et al., 2011) and humans (Chamoun
et al., 2010), have shown that glutamate concentrations increase
in the acute phase following injury, whereas magnetic resonance
spectroscopy (MRS) studies have shown a persistent decrease
in glutamate concentrations following injury. The reason for
this discrepancy is that microdialysis measures extracellular
glutamate, while MRS measures both intra and extracellular
glutamate (Guerriero et al., 2015).
Specifically in the hippocampus, glutamate decreases
following moderate to severe temporal cortex injury, as
measured by in vivo proton MRS in a direct cortical injury model
in rodents (Harris et al., 2012). Although the hippocampus was
considered perilesional tissue in this experiment, the temporal
neocortex, i.e., the lesional tissue, also showed a decrease in
glutamate in the acute phase. Human MRS studies also in the
acute phase following concussion, however, showed no changes
in hippocampal glutamate concentrations, despite finding
decreased glutamate levels in the motor cortex (Henry et al.,
2010). A reason for this discrepancy may be that the human
study was in patients with mTBI, whereas the rodent study
looked at moderate to severe TBI.
Another important compound altered in the hippocampus
after TBI is the neurotransmitter gamma-aminobutyric acid
(GABA). The expression of various GABA receptor subunits
is changed, causing reductions of inhibitory postsynaptic
currents and increases in excitatory post-synaptic currents
after TBI in rodents (Hunt et al., 2011; Almeida-Suhett
et al., 2015; Drexel et al., 2015). As a result, deficits occur
in long-term potentiation, which can translate into cognitive
impairment. Similarly, up and down-regulation of other
proteins can lead to impairments in hippocampal synaptic
transmission, including those involved in the extracellular
signal-regulated kinase (ERK) pathways (Atkins et al.,
2009), and the soluble N-ethylmaleimide-sensitive factor
attachment protein receptor (SNARE) complex (Carlson et al.,
2016).
The regulation of gene transcription affects not only the
creation of proteins involved in neurotransmission after injury,
but also the synthesis of neurons themselves. Because TBI is
associated with hippocampal neuronal damage and death, it
is important to develop therapeutic strategies to either protect
immature neurons or enhance neurogenesis in the hippocampus
after injury. Methods shown to drive neurogenesis post injury
include forced overexpression of insulin-like growth factor 1
(IGF-1; Carlson et al., 2014), and the transplantation of synthetic
human progenitor cells into the hippocampus after TBI (Blaya
et al., 2015). Interestingly, TBI severity has been found to
correlate with the degree of post-traumatic neurogenesis in rat
hippocampus. Whereas mTBI had no effect on neurogenesis,
moderate TBI promoted neural stem cell proliferation without
increasing neurogenesis, and severe TBI increased neurogenesis
(Wang et al., 2015a). A summary of the biochemical and genetic
changes following TBI in rodent hippocampus can be found in
Table 1.
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TABLE 1 | Biochemical changes in rodent hippocampus following TBI, with effects categorized by subsection of the hippocampal complex.
Structure Biochemical changes after TBI
CA1 Decreased surface expression of α1, ß2/3, and γ2 subunits of the GABAA receptor caused reductions in the frequency and
amplitude of spontaneous and miniature GABAA-receptor mediated inhibitory postsynaptic currents after TBI in rats. This led to
deficits in long-term potentiation of synaptic transmission (Almeida-Suhett et al., 2015).
CA1, CA3 Expression of GABAA and GABAB receptor subunit mRNAs α4 (GCL, CA3, CA1), α5 (CA1) and γ2 (GCL, CA3, CA1) was up-
regulated after TBI in rats, with many of the changes being reversible (Drexel et al., 2015).
CA1, dentate Mechanical stimulation using a stretchable microelectrode array disrupted bicuculline (GABAA antagonist) induced long-lasting
network synchronization 24 h after TBI, despite the continued ability of injured neurons to fire (Kang et al., 2015).
CA4 Action potential and excitatory post-synaptic current frequencies were increased in hilar GABA neurons after TBI in mice, with a
further increase observed after photostimulation of dentate granule cell or CA3 pyramidal cell layers (Hunt et al., 2011).
Dentate TBI severity affected hippocampal neurogenesis in rats: mild TBI did not affect neurogenesis; moderate TBI promoted neural
stem cell proliferation without increasing neurogenesis; severe TBI increased neurogenesis (Wang et al., 2015a).
Survivin (apoptosis protein inhibitor) down-regulation inhibited adult hippocampal neurogenesis, promoted apoptotic cell death,
and worsened memory capacity on water maze testing, after TBI in mice (Zhang et al., 2015).
Entire hippocampal complex Several microRNAs are significantly altered in hippocampal mitochondria and cytoplasm, including elevated levels of miR-155
and miR-223 (play a role in inflammation), after TBI in rats (Wang et al., 2015b).
Synthetic, human multineurotrophin neural progenitor cells (MNTS1-NPCs) conferred significant preservation of pericontusional
host tissues and enhanced hippocampal neurogenesis after TBI in rats (Blaya et al., 2015).
Inhibition of population spikes was reduced in the Schaffer collateral pathway (CA3 to CA1) 2 days after TBI in rats, while increases
in inhibition in the dentate gyrus (corresponding to increased GABA levels) was seen at both 2 and 15 days after injury (Reeves
et al., 1997).
Decreased field excitatory post-synaptic potentials were recorded in hippocampal subfield CA1 in response to electrical
stimulation of the Schaffer collaterals, following TBI in vitro, indicating that expression of long-term potentiation and synaptic
plasticity was inhibited following TBI (Sick et al., 1998).
Gene transcriptome study identified upregulation of 193 transcripts and downregulation of 21 transcripts in the hippocampus,
affecting mostly the transcription of non-neuronal genes, 24 h after mild TBI in mice (Samal et al., 2015).
Hippocampus nuclear factor of activated T cells (NFAT) c3 levels (expressed in astrocytes) were decreased both in the cytoplasmic
and nuclear fractions, while NFATc4 levels (expressed in neurons) were increased in the cytoplasmic fraction but decreased in the
nuclear fraction, after TBI in rats (Yan et al., 2014).
Insulin-like growth factor 1 (IGF-1) promotes neurogenesis after TBI in mice, in that overexpression of IGF-1 resulted in a marked
increase in immature neuron density in the subgranular zone at 10 days after injury (Carlson et al., 2014).
Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex was reduced in rat hippocampus
following TBI, and resulted in a significant reduction in synaptic vesicle number (Carlson et al., 2016).
TBI in rats results in chronic signaling deficits through the extracellular signal-regulated kinase (ERK)—cAMP response element-
binding protein (CREB) pathway in the hippocampus (Atkins et al., 2009).
Up-regulation of mRNA and protein for Nav1.6 (a voltage-gated sodium channels alpha subunit) occurred in rat hippocampal
neurons after TBI (Mao et al., 2010).
Nuclear factor erythoid related factor 2 (NRF2, transcription factor) mRNA increased significantly post-TBI at 48 and 72 h and 1
week in the hippocampus with a coincident increase in glial fibrillary acidic protein mRNA, overlapping with heme-oxygenase-1,
nicotinamide adenine dinucleotide phosphate-quinone-oxidoreductase 1, glutathione reductase, and catalase mRNA (Miller et al.,
2014).
CA, cornu ammonis; GABA, gamma-aminobutyric acid; GCL, granule cell layer; RNA, ribonucleic acid.
HIPPOCAMPUS BIOCHEMICAL
PATHWAYS AND NEUROPROTECTIVE
AGENTS IN mTBI
Since mechanisms of secondary injury after mTBI are similar
to other diseases, it is likely that drugs that are already in use
for other indications may have efficacy for mTBI as well. One
example of such a mechanism is the glucagon-like peptide-1
(GLP-1) signaling pathway. GLP-1 was initially described based
on its role in the pancreatic regulation of insulin, but receptors
are also found in the CNS and changes in this pathway have
been implicated in a number of neurodegenerative diseases (Li
et al., 2009, 2010, 2012; Martin et al., 2009; Salcedo et al.,
2012). Through coupling to a cAMP second messenger pathway,
activation of GLP-1 receptors elicits neurotrophic actions such
as neuritic growth while protecting neurons against various
insults (Perry et al., 2002). As a result, there have been a
number of investigations into modulation of this pathway to treat
neurological disease.
Exendin-4 is a synthetic GLP-1 receptor agonist currently
approved as a drug for the treatment of hyperglycemia in
type-2 diabetes that crosses the blood brain barrier (Kastin
and Akerstrom, 2003). When administered after mTBI, this
neuroprotective agent has been shown to prevent changes in
rodent hippocampal gene expression following mTBI. Many of
these genes protected by Exendin-4 are also associated with
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memory loss in AD (which has been associated with TBI),
and administration ameliorated memory deficits after injury
(Tweedie et al., 2013). Additional rodent studies using markers
of cell death have shown that Exedin-4 improved hydrogen
peroxide mediated oxidative stress and glutamate toxicity in
neuronal cultures in vitro. In vivo, using markers of cognitive
function, the drug ameliorated mTBI-induced deficits in novel
object recognition and maze testing, both when administered
prior to and after the insult (Eakin et al., 2013; Rachmany
et al., 2013). Therefore, data is emerging to support a shift in
indication for the use of Exedin-4 from an antihyperglycemic
medication to a potential agent to minimize secondary injury
after mTBI.
Another agent with potential efficacy for secondary injury
after mTBI is N-Acetyl-cystein (NAC), which is currently used as
a mucolytic agent and an antidote to acetaminophen overdose.
NAC has been shown to have antioxidant and neurovascular-
protective effects after mTBI (Ellis et al., 1991; Hicdonmez
et al., 2006; Chen et al., 2008) and has been demonstrated to
reverse behavioral deficits in mTBI rodents when administered
30–60 min after injury (Eakin et al., 2014). Specifically in the
hippocampus, NAC was found to decrease levels of cytosolic-
free Ca2+ and reactive oxygen species, reduce apoptosis, and
lower caspase-3 and -9 neuronal activities, following TBI in rats
(Nazirog˘ lu et al., 2014). In humans, NAC has been shown in a
randomized double-blind trial to improve auditory, vestibular,
and cognitive functional sequelae after blast-induced mTBI in
military personnel (Hoffer et al., 2013). Although the mechanism
of action in the trauma setting has yet to be elucidated, the 40 year
safety profile and ease of administration of the medication makes
it an attractive option for widespread use.
Numerous other compounds have been found to exert
effects in the hippocampus following injury. As summarized in
Table 2, different substances affect different subsections of the
hippocampal complex. Although all these investigations were
performed in rodents, several of these biochemical compounds
may prove to have beneficial effects in humans suffering from
cognitive and memory impairments following TBI.
HIPPOCAMPAL CIRCUITRY AND
NEUROPHYSIOLOGIC CHANGES AFTER
mTBI
In addition to biochemical changes after injury, changes in
electrical neural activity also play a role in the sequelae of
TBI. The high prevalence of memory deficits after injury point
to a relative vulnerability of the hippocampus and mesial
temporal structures as compared to the rest of the brain (Hamm
et al., 1993; Finset et al., 1999; Comper et al., 2005), and
electrophysiologic studies have shown that changes occur in
hippocampal circuit excitability after TBI (Witgen et al., 2005;
Ortiz and Gutiérrez, 2015). In addition, moderate and severe
TBI is associated with neuronal cell loss in several hippocampal
regions (Lowenstein et al., 1992) as well as alterations in cellular
homeostasis (D’Ambrosio et al., 1999) and dysregulated synaptic
transmission (Toth et al., 1997; D’Ambrosio et al., 1998) in this
region. On the other hand, mTBI has been associated with more
subtle changes in firing patterns that are present even in the
absence of morphological changes.
Studies comparing control rats to those who had undergone
lateral fluid percussion induced mTBI found changes in working
memory in the absence of differences in histology or neuronal
loss (Eakin and Miller, 2012). Single unit recordings from cornu
ammonis 1 (CA1) and CA3 subfields during a working memory
task showed no differences in firing rates or spike characteristics
between the two groups, but rats exposed to mTBI were found
to have significantly fewer cells with spatiotemporal activity, and
this correlated with task performance. Moreover, in a similar
experiment looking at the burst characteristics of hippocampal
cells during an object exploration task, memory deficits were
found to be associated with decreased burst activity of certain
subsets of neurons within the pyramidal cell layer (Munyon
et al., 2014). Therefore, functional impairment may stem from an
alteration in the activity of certain subpopulations of cells within
the hippocampus.
These changes in neuronal firing patterns within the
hippocampus can persist after TBI and correlate with changes
in cognitive function (Witgen et al., 2005). In the analysis
of local field potentials after injury, hippocampal broadband
power decreased (Paterno et al., 2015), and specifically disruption
of theta rhythm (4–7 Hz) has been implicated in the
pathophysiology of memory loss (Winson, 1978; Fedor et al.,
2010). It has been theorized that using electrical stimulation
to artificially counteract and reverse these disrupted firing
patterns within the hippocampus and other structures may
regulate cellular and network processes and restore functional
memory circuits (Diamond et al., 1988; Nakao et al., 2003;
Shirvalkar et al., 2010; Tabansky et al., 2014; Hanell et al.,
2015). Accordingly, theta burst stimulation (200 Hz in 50 ms
trains, five trains per second; 60 mA biphasic pulses) delivered
to the fornix of rats with mTBI improved deficits in learning
and memory, whereas non-oscillatory low or high frequency
stimulation did not (Sweet et al., 2014). In a related manner,
theta band stimulation of the medial septal nucleus of mTBI
rats resulted in a transient increase in hippocampal theta
activity and improved spatial working memory (Lee et al.,
2013), whereas 100 Hz gamma stimulation did not (Lee et al.,
2015).
In humans, theta burst stimulation of the fornix has been
studied in patients undergoing stereo-electroencephalography
evaluation for drug-resistant epilepsy, and was shown to produce
evoked potentials in the ipsilateral hippocampus. This resulted
in significant and reversible improvements in immediate and
delayed performance on a visual-spatial memory task (Miller
et al., 2015). Temporally patterned stimulation paradigms
may therefore present novel neuromodulatory strategies in
the treatment of post-traumatic memory loss and cognitive
deficits. Potential targets include the hippocampus, its associated
white matter tracts, as well as the medial prefrontal cortex.
The dysfunction of the latter is thought to play a role in the failure
of emotion regulation after mTBI through top down amygdalar
regulation (van der Horn et al., 2016), a mechanism that may
result in persistent post-concussive symptoms.
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TABLE 2 | Biochemical compounds investigated in rodent hippocampus following TBI, with effects categorized by subsection of the hippocampal
complex.
Structure Compound Effects
CA1 WIN55, 212-2 WIN55,212-2 (synthetic cannabinoid) restored CA1 interneuron GABAergic signaling after TBI in mice
(Johnson et al., 2014).
CA2, CA3 NT4/5 Recombinant Neurotrophin-4/5 (Trk-B ligand) increased survival of CA2/3 pyramidal neurons after
TBI in rats, but did not improve functional outcome (Royo et al., 2007).
CA1, CA3, Dentate gyrus MK-801 MK-801 (competitive NMDA receptor antagonist) ameliorated hippocampal neuronal loss after TBI in
rats, and improved anxiety and hippocampus dependent memory (Sönmez et al., 2015).
Dentate gyrus Rapamycin Rapamycin (mTOR inhibitor) reduced dentate granule cell area, neurogenesis, and mossy fiber
sprouting; increased recurrent excitation of dentate granule cells; and diminished seizure prevalence
after TBI in rats (Butler et al., 2015).
Ara-C Ara-C (arabinofuranosyl cytidine, antimitotic agent) reduced progenitor cell proliferation and
neurogenesis in the dentate gyrus, and completely abolished innate cognitive recovery on water
maze performance, after TBI in rats (Sun et al., 2015).
Clioquinol Clioquinol (zinc chelator) reduced progenitor cell proliferation and neurogenesis after TBI in rats (Choi
et al., 2014).
Entire hippocampal complex DHF DHF (7,8-dihydroxyflavone, brain derived neurotrophic factor imitator) increased the number of adult-
born immature neurons in the hippocampus, and promoted their dendrite arborization in the injured
brain following TBI in mice (Zhao et al., 2015).
NAC + selenium N-acetylcysteine (NAC) and selenium (antioxidants) decreased levels of cytosolic-free Ca2+,
apoptosis, cytosolic reactive oxygen species levels, and caspase-3 and -9 activities in hippocampal
neurons, after TBI in rats (Nazirog˘lu et al., 2014).
SB-3CT SB-3CT (matrix metallopeptidase nine inhibitor) preserved hippocampal neurons and prevented
declines in motor function and memory, following TBI in rats Jia et al., 2014).
Oxaloacetate + pyruvate Oxaloacetate and pyruvate (blood glutamate scavengers) increased hippocampus neuronal survival
and neurologic severity scores, after TBI in rats (Zlotnik et al., 2012).
Thymoquinone Thymoquinone (phytochemical compound) increased hippocampus neuronal densities and
malondialdehyde levels, after TBI in rats (Gülsen et al., 2015).
Indomethacin Indomethacin (anti-inflammatory) suppressed Nogo-A (membrane protein important in axonal
remodeling) expression, leading to decreased levels of IL-1β, therefore lessening neuronal damage
after TBI in rats (Chao et al., 2012).
CA, cornu ammonis; GABA, gamma-aminobutyric acid; Trk, tyrosine kinase; NMDA, N-methyl-D-aspartate; mTOR, mammalian Target Of Rapamycin; IL-1β, Interleukin-1
beta.
IMAGING IN mTBI
Recent advances in imaging have allowed for in-depth structural
analysis of brain regions both acutely after concussive injury and
in the chronic phase. This is important because the ability to
identify abnormalities that may previously have been missed is
the first step in developing modalities to treat these phenomena,
or in the least decide which patients require treatment. Although
no single imaging modality has yet proven to be sufficient for
all patients with TBI due to the heterogeneity of the condition
(Amyot et al., 2015), each method offers its own advantages.
Conventional magnetic resonance imaging (MRI) and
computed tomography (CT) are typically negative in mTBI
patients with persistent symptoms of post-concussive syndrome.
However, compared to controls, mTBI patients were found to
have lower cortical thickness of the right temporal lobe and
left insula, and increasing number of mTBIs was associated
with lower cortical thickness in more brain areas, including
bilateral insula, right middle temporal gyrus, and right entorhinal
area (List et al., 2015). These findings are worrisome because
if further deterioration of these structures occur as part of
the aging process, subtle cognitive symptoms may progress to
clinical dementia earlier than in age-matched controls. Diffusion
tensor imaging is another technique that has recently emerged
as a powerful adjunct to conventional MRI. It enables the
measurement of fractional anisotropy, a value that indicates the
degree of restriction experienced by water molecules diffusing
along white matter fibers. Such a tool offers a noninvasive
glimpse into the neurophysiology of these tracts and may allow
detection of demyelination and axonal damage that would
otherwise be missed on a conventional MRI. Indeed, fractional
anisotropy was significantly reduced in the right superior
longitudinal fasciculus of patients with mTBI and normal MRI as
compared with controls, showing that diffusion tensor imaging is
more sensitive than standard imaging in this population (Adam
et al., 2015). Another study showed similar but subtler findings,
as only those with mTBI who had abnormalities on conventional
MRI had white matter changes on diffusion tensor imaging
(Panenka et al., 2015).
Although increasing abnormality on post-injury CT and
MRI correlate with lower neuropsychological performance
(Bigler et al., 2015), diffusion tensor imaging has also
shown promise in predicting neuropsychological outcomes
following mTBI in patients with normal CT and MRI.
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Immediately following injury and 6 months post-trauma,
patients with mTBI showed significant differences in
fractional anisotropy and radial diffusivity as compared to
controls, specifically in the corona radiata, anterior limb of
internal capsule, cingulum, superior longitudinal fasciculus,
optic radiation, and genu of corpus callosum, changes
which demonstrated associations with neuropsychological
outcomes across both time points (Veeramuthu et al.,
2015). Another study has shown significantly reduced
fractional anisotropy in the internal capsule of both TBI and
depression patients (Maller et al., 2010), further underscoring
the potential role for diffusion tensor imaging as a noninvasive
biomarker useful in the prognostication of post-concussive
symptoms.
MRS is another noninvasive technique that measures
metabolic changes within brain tissue. In combination with
vascular imaging techniques such as transcranial Doppler
ultrasound, these modalities have begun to shed light on
metabolic processes and the control and regulation of cerebral
blood flow following mTBI (Len and Neary, 2011). In the
hippocampus, N-acetyl aspartate to choline and N-acetyl
aspartate to creatine ratios were decreased in patients with
mTBI in comparison to control subjects (Hetherington et al.,
2014). Similar changes were found following mTBI in the
thalamus, with a reduction of N-acetyl aspartate to creatine
and choline to creatine ratios, findings that are classically
associated with ischemia (Sours et al., 2015). Of interest, these
results correlated with self-reported sensory symptoms, leading
the authors to speculate that novel interventions could target
these changes in the hopes of treating patients with persistent
post-concussive symptoms, as well as use the absence of such
imaging features as an indicator to help predict safe return to
work.
Magnetoencephalography is an imaging modality largely
restricted to the study of epilepsy, but may prove useful as
a sensitive detector of local field potentials in brain areas
affected by mTBI. A recent innovative study looked at the
tracking of eye movements as a marker for sustained attention
over time and internal anticipatory control, measurements
that are impaired in chronic mTBI while the patients were
undergoing magnetoencephalography (Diwakar et al., 2015).
Compared to controls, mTBI patients demonstrated impaired
eye tracking that was concurrent with abnormal beta activity,
which was suppressed in the right parietal cortex and
enhanced in the left caudate and frontal-temporal areas. The
clinical significance of these findings is yet to be seen, but
this is a strong example of novel imaging methods being
used in new and original ways to better understand the
neurophysiology of injured neural circuits, methods that may
alter the manner in which mTBI is diagnosed and treated in the
future.
FUTURE DIRECTIONS
Direct modulation of neural activity via deep brain stimulation
(DBS) currently does not play a direct role in the setting
mTBI, but it does carry promise in the treatment of
post-concussive affective disorders, trauma-induced tremor, and
neurodegenerative disorders. DBS is an effective treatment for
certain patients with severe major depression (Lozano et al.,
2012) and obsessive-compulsive disorder (Kisely et al., 2014),
but has yet to be investigated in the treatment of these disorders
following brain injury. Likewise, PD often responds well to DBS
of the subthalamic nucleus or globus pallidus internus (Okun,
2012), but data is lacking in the setting of trauma-induced
Parkinson’s. However, tremor following severe brain injury has
been shown in small studies to respond to both thalamic and
pallidal DBS (Issar et al., 2013; Carvalho et al., 2014).
If neurostimulation augments improvements in cognitive
deficits after brain injury, memory disorders may present other
potential applications for DBS (Shin et al., 2014). Forniceal DBS
in a mouse model of Rett syndrome restored in vivo hippocampal
long-term potentiation and neurogenesis, and rescued contextual
fear memory and spatial learning (Hao et al., 2015). In humans,
the fornix and nucleus basalis of Meynert are being investigated
as possible DBS targets for improvement of memory in the
treatment of AD (Sankar et al., 2014; Suthana and Fried, 2014).
Although these strategies seem promising, they will likely be
tested for efficacy and safety in the setting of severe TBI, prior
to being applied in patients with mTBI.
Less invasive neuromodulation options for the treatment
of mTBI include transcranial magnetic stimulation (TMS) and
transcranial direct current stimulation (TDCS). TMS uses a
surface coil to create a low frequency electric current that is
delivered to the surface of the brain, while TDCS uses electrodes
placed directly on the scalp. There is evidence in severe TBI
that TMS may aid in motor recovery, aphasia, visuospatial
neglect (Castel-Lacanal et al., 2014), and cognitive function
(Polanowska and Seniów, 2010), but high frequencies are
contraindicated due to the risk of seizures, especially in the
setting of trauma as the injured brain is already predisposed to
epileptiform activity. TDCS uses lower currents and therefore
has a lower risk of seizures, but subsequently may also have
less clinical effect, as current studies show mixed results in
the treatment of post-concussive symptoms (Kang et al., 2012;
Les´niak et al., 2014; Ulam et al., 2015). TMS is currently the
most extensively studied brain stimulation modality in TBI,
but most interventions have been non-targeted and focused on
the chronic phase of recovery after the injury (Li et al., 2015).
As can be expected, better clinical outcomes occur when these
neuromodulatory approaches are coupled with cognitive therapy
and neurorehabilitation (Chantsoulis et al., 2015; Page et al.,
2015).
Finally, nanotechnology and brain-computer interfaces may
present new opportunities. By using a computer to bridge the
gap between the brain and peripheral nerves in the setting of
an injured spinal cord, brain-computer interfaces are ‘‘a form
of extended embodiment that become integrated into the
individual’s conception of himself as an autonomous agent’’
(Glannon, 2014). Such systems are still in the experimental
stage, but offer hope to those patients with severe motor
deficits. Similarly, carbon nanotubes are being used to synthesize
nanoelectrode arrays that permit real time monitoring and
modulation of electrochemical events at the neural and synaptic
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level (Andrews, 2007), and may offer a glimpse into the
future of the field of neuromodulation. As with DBS, however,
these modalities will likely be reserved for patients with severe
TBI until efficacy, safety, and economic feasibility can be
established.
CONCLUSION
Despite the high incidence and prevalence of mTBI, only
recently have the pathophysiologic mechanisms begun to
emerge. Understanding the biochemical signaling pathways
involved in the propagation of secondary injury mechanisms
has led to the discovery of novel uses for medications
currently used for other indications. Biochemical markers
and advances in imaging are allowing for earlier diagnosis
of concussions, and developments in the area of DBS for the
treatment of memory and affective disorders are creating
new avenues for the management of post-concussive
syndrome. Ultimately, these advances in neuromodulation
strive to improve outcomes in mTBI and substantially
impact the lives of patients and families suffering from this
condition.
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